GRASSI, GABRIELE
 Distribuzione geografica
Continente #
EU - Europa 36.216
NA - Nord America 23.275
AS - Asia 11.869
SA - Sud America 1.361
AF - Africa 347
OC - Oceania 77
Continente sconosciuto - Info sul continente non disponibili 36
AN - Antartide 1
Totale 73.182
Nazione #
IT - Italia 23.830
US - Stati Uniti d'America 22.859
SG - Singapore 4.112
CN - Cina 3.085
PL - Polonia 2.214
DE - Germania 1.786
SE - Svezia 1.680
FR - Francia 1.202
HK - Hong Kong 1.160
VN - Vietnam 1.160
UA - Ucraina 1.073
BR - Brasile 1.018
GB - Regno Unito 893
RU - Federazione Russa 813
KR - Corea 757
FI - Finlandia 647
NL - Olanda 549
TR - Turchia 499
IN - India 301
IE - Irlanda 293
BG - Bulgaria 283
CH - Svizzera 247
CA - Canada 233
MA - Marocco 123
BE - Belgio 119
MX - Messico 112
ES - Italia 107
JP - Giappone 107
BD - Bangladesh 94
AR - Argentina 91
IQ - Iraq 69
AU - Australia 68
RO - Romania 67
IR - Iran 65
AT - Austria 64
ZA - Sudafrica 55
EC - Ecuador 52
SA - Arabia Saudita 50
ID - Indonesia 49
CO - Colombia 45
SN - Senegal 44
CZ - Repubblica Ceca 41
PK - Pakistan 40
AL - Albania 39
CL - Cile 38
VE - Venezuela 38
TH - Thailandia 33
GR - Grecia 32
PY - Paraguay 32
EU - Europa 31
EG - Egitto 30
IL - Israele 30
PH - Filippine 30
PT - Portogallo 30
MY - Malesia 29
LU - Lussemburgo 27
UZ - Uzbekistan 27
DK - Danimarca 26
PE - Perù 25
TW - Taiwan 25
SI - Slovenia 23
DZ - Algeria 22
HR - Croazia 21
KE - Kenya 20
LT - Lituania 20
JO - Giordania 19
RS - Serbia 18
AE - Emirati Arabi Uniti 17
AZ - Azerbaigian 14
JM - Giamaica 13
NO - Norvegia 12
TN - Tunisia 12
HU - Ungheria 11
PA - Panama 11
UY - Uruguay 11
GE - Georgia 10
KZ - Kazakistan 10
EE - Estonia 9
NP - Nepal 9
CR - Costa Rica 8
AO - Angola 7
BO - Bolivia 7
DO - Repubblica Dominicana 7
KG - Kirghizistan 7
MD - Moldavia 7
NZ - Nuova Zelanda 7
OM - Oman 7
SK - Slovacchia (Repubblica Slovacca) 7
BY - Bielorussia 6
GD - Grenada 6
LB - Libano 6
LV - Lettonia 6
MO - Macao, regione amministrativa speciale della Cina 6
SM - San Marino 6
TT - Trinidad e Tobago 6
BH - Bahrain 5
ET - Etiopia 5
KH - Cambogia 5
NG - Nigeria 5
NI - Nicaragua 5
Totale 73.091
Città #
Singapore 2.369
Ashburn 2.314
Woodbridge 1.947
Warsaw 1.892
Ann Arbor 1.797
Fairfield 1.770
Chandler 1.607
Houston 1.369
Milan 1.225
Rome 1.224
Trieste 1.213
Hong Kong 1.103
San Jose 1.075
Jacksonville 1.011
Wilmington 873
Hefei 796
Beijing 747
Seoul 715
Seattle 700
Cambridge 596
Princeton 490
Boardman 480
Izmir 392
Chicago 354
Naples 353
Ho Chi Minh City 350
Santa Clara 325
Los Angeles 314
Dearborn 302
Columbus 296
Dublin 282
Lauterbourg 276
Sofia 276
The Dalles 273
Dallas 266
Hanoi 260
Florence 259
Moscow 251
Helsinki 237
Bologna 232
Zgierz 229
Turin 222
Padova 196
London 176
Palermo 176
Napoli 157
Council Bluffs 156
Buffalo 149
Frankfurt am Main 147
Munich 146
Düsseldorf 143
Bari 123
Torino 118
Genoa 116
New York 116
Brescia 110
San Diego 105
São Paulo 102
Catania 101
Brussels 95
Verona 90
Venezia 89
Casablanca 88
Udine 88
Redwood City 86
Cagliari 83
Orem 81
Grafing 74
North Bergen 74
Shanghai 73
Tokyo 71
Venice 71
Guangzhou 69
Amsterdam 68
Bern 68
Perugia 67
Redmond 67
Bergamo 65
Haiphong 64
Turku 64
Toronto 62
Bremen 58
Chennai 57
Mestre 57
Montreal 57
Washington 57
Treviso 56
Da Nang 54
Phoenix 53
Monza 52
Como 50
Des Moines 49
Nanjing 49
Genova 48
Mountain View 48
Pescara 48
Salerno 47
Caserta 46
Atlanta 45
Messina 45
Totale 38.032
Nome #
Valutazione quantitativa di Ki-67 nel carcinoma mammario: comparazione tra lettura al microscopio ottico e lettura con analizzatore automatico 21.794
VALUTAZIONE DEL TOUCH-IMPRINT CITOLOGICO NEL TRATTAMENTO DEL CANCRO DELLA MAMMELLA 1.342
Polysaccharides for the delivery of antitumor drugs 473
Polymer-mediated delivery of siRNAs to hepatocellular carcinoma: Variables affecting specificity and effectiveness 473
Keratin14 mRNA expression in human pneumocytes during quiescence, repair and disease 465
Potential applications of nanocellulose-containing materials in the biomedical field 455
A nanoporous surface is essential for glomerular podocyte differentiation in three-dimensional culture. 437
Effect of cystic fibrosis sputum rheology on lungs drug delivery by inhalation 416
GT75 aptamer against eukaryotic elongation factor 1A as potential anticancer drug for castrate-resistant prostate cancer (CRPC). 392
Antibacterial drug release from a biphasic gel system: Mathematical modelling 375
Use of low field NMR for the characterization of gels and biological tissues 372
Theoretical importance of pvp-alginate hydrogels structure on drug release kinetics 353
Therapeutic potential of small interfering RNAs/micro interfering RNA in hepatocellular carcinoma 349
Physical characterization of alginate–Pluronic F127 gel for endoluminal NABDs delivery 336
Strategies for delivery of siRNAs to ovarian cancer cells 329
Combined Used of Rheology and LF-NMR for the Characterization of PVP-Alginates Gels Containing Liposomes 323
Survival and Prognostic Factors in Mixed Cryoglobulinemia: Data from 246 Cases 322
Therapeutic potential of Nucleic acid-based drugs in coronary hyper-proliferative vascular diseases 306
Breastfeeding is an additional protective factor for breast cancer among women living in the metropolitan area of Trieste. 304
Therapeutic potential and delivery strategies for nucleic acid-based drugs 300
Parità e Allattamento quali fattori protettivi di carcinoma mammario nelle donne triestine 300
In vitro metabolic zonation through oxygen gradient on a chip 297
Characterization of PLLA scaffolds for biomedical applications 295
Engineering approaches in siRNA delivery 294
Oral anticoagulation and VKORC1 polymorphism in patients with a mechanical heart prosthesis: a 6-year follow-up 293
Studio matematico di un sistema antiossidante per uso alimentare a base di acido ascorbico 293
The role of the transcription factor E2F1 in hepatocellular carcinoma 292
Strategies to optimize siRNA delivery to hepatocellular carcinoma cells 282
Serum Response Factor depletion affects the proliferation of the hepatocellular carcinoma cells HepG2 and JHH6 279
Novel Lipid and Polymeric Materials as Delivery Systems for Nucleic Acid Based Drugs 278
Recent advances in smart biotechnology: Hydrogels and nanocarriers for tailored bioactive molecules depot 278
A physiologically-oriented mathematical model for the description of in vivo drug release and absorption 275
Ottimizzazione di hydrogel alginato-pluronico per il rilascio di farmaci basati sul DNA 274
Growth Rate of Small Abdominal Aortic Aneurysms and Genetic Polymorphisms of Matrix MetalloProteases-1, -3, and -9 273
Synthesis and characterization of UV photocrosslinkable hydrogels with poly(N-vinyl-2-pyrrolidone): Determination of the network mesh size distribution 272
2D DYNAMICAL SIMULATION OF A VIBRATIONAL MILL 271
Exploring the Shape Influence on Melting Temperature, Enthalpy, and Solubility of Organic Drug Nanocrystals by a Thermodynamic Model 271
Thermo-responsive hydrogels from cellulose-based polyelectrolytes and catanionic vesicles for biomedical application 271
Decreased IL-10 mRNA expression in patients with advanced renal failure undergoing conservative treatment 269
Chemical engineering in the “BIO” world 268
Use of Low field NMR for the characterisation of gels and biological tissues 267
Mathematical modeling of drug release from natural polysaccharides based matrices 266
Current strategies to improve the efficacy and the delivery of nucleic acid based drugs 264
A novel approach based on low-field NMR for the detection of the pathological components of sputum in cystic fibrosis patients 263
Mathematical modeling of L-(+)-ascorbic acid delivery from pectin films (packaging) to agar hydrogels (food) 259
Membranes in Drug Delivery 255
Dissecting the role of the elongation factor 1A isoforms in hepatocellular carcinoma cells by liposome-mediated delivery of siRNAs 255
Characterization of nucleic acid molecule/liposome complexes and rheological effects on pluronic/alginate matrices 253
Features of vulnerable plaques and clinical outcome of UA/NSTEMI: Relationship with matrix metalloproteinase finctional polymorphisms. 252
Bortezomib arrests the proliferation of hepatocellular carcinoma cells HepG2 and JHH6 by differentially affecting E2F1, p21 and p27 levels. 250
Can low field nuclear magnetic resonance be used to monitor lung functionality of cystic fibrosis patients? 249
Aptamer targeting of the elongation factor 1A impairs hepatocarcinoma cells viability and potentiates bortezomib and idarubicin effects 248
Alcohol reduces MMP-2 in humans and isolated smooth muscle cells. 244
Diagnostic and prognostic role of eEF1A in chronic lymphocytic leukaemia 244
Drug delivery from polymeric matrices 243
Designing of polymeric gels mimicking the normal and fibrotic liver tissues: Effect of viscoelasticity on cells adhesion and survival 240
Mass balance: an old concept for the new challenges proposed by personalized medicine 239
Monitoring sputum properties in cystic fibrosis patients by means of Low-Field NMR before after kaftrio treatment 238
A rapid and specific method to simultaneously quantify eukaryoticelongation factor 1A1 and A2 protein levels in cancer cells 238
Rilascio di farmaci da matrici viscoelastiche: punto di incontro tra modello e dati sperimentali 235
Modulating carbohydrate-based hydrogels as viscoelastic lubricant substitute for articular cartilages 235
Translation Elongation 233
Impairment of the Pin1/E2F1 axis in the anti-proliferative effect of bortezomib in hepatocellular carcinoma cells 233
An update of aberrant methylation detection on circulating cell-free DNA as a tool to improve prostate cancer diagnosis and prognosis 233
Effects of E2F1-cyclinE1-E2 circuit down-regulation in hepatocellular carcinoma cells 232
Can rheology be useful in the cystic fibrosis frame 230
Virtual screening identifies a PIN1 inhibitor with possible antiovarian cancer effects 227
METODO E CONNESSO APPARATO PER ANALISI DI UN CAMPIONE DI ESPETTORATO 227
A rapid procedure for the quantitation of low abundance RNAs by competitive reverse transcription-polymerase chain reaction 226
Dissecting the expression of EEF1A1/A2 genes in human prostate cancer cells: the potential od EEF1A2 as a hallmark for prostate transformation and progression 226
Novel design of drug delivery in stented arteries: a numerical comparative study 225
Aptamers as nano-targeting delivery devices or anti-cancer drugs for fighting tumours 224
Mathematical modelling of antibacterial release from a biphasic gel system 220
Combined use of rheology and portable low-field NMR in cystic fibrosis patients 215
Hydrogel basati sul PVP per il drug delivery da microcontainer 214
Swelling of viscoelastic matrices by viscoelastic fluids 213
Characterisation of nucleid acid molecule/liposome complexes and rheological effects on pluronic/alginate matrices 211
A siRNA targeted against SRF reduce hepatocellular carcinoma cell proliferation, showing its potential use in the growth inhibition of this type of tumor 210
"Charactherization of nucleic acid molecule/liposome complexes and rheological effects on pluronic/alginate matrices" 209
Caratterizzazione reologico/NMR di gel composti da alginato-pluronico per il rilascio di farmaci basati sul DNA 204
Effects of hypoxia and bed rest on markers of cardiometabolic risk: Compensatory changes in circulating trail and glutathione redox capacity 204
A siRNA targeted against SRF reduce hepatocellular carcinoma cell proliferation, showing its potential use in the growth inhibition of this type of tumor 203
Correlazione vitro-vivo e modelli matematici 203
null 203
Effects of eEF1A1 targeting by aptamer/siRNA in chronic lymphocytic leukaemia cells 203
Cleavage of collagen RNA transcripts by hammerhead ribozymes in vitro is mutation-specific and shows competitive binding effects 202
The expression levels of the translational factors eEF1A 1/2 correlate with cell growth but not apoptosis in hepatocellular carcinoma cell lines with different differentiation grade 201
PDPG Polymer as a targeted delivery system for siRNAs to hepatocellular carcinoma cells 200
Novel hepatocellular carcinoma molecules with prognostic and therapeutic potentials 199
Relation between the plasma levels of LDL-cholesterol and the expression of the early marker of inflammation long pentraxin PTX3 and the stress response gene p66ShcA in pacemaker-implanted patients. 199
Use of Rheology and portable Low-Field NMR for the monitoring of lung functions in cystic fibrosis patients 198
YAP–TEAD1 control of cytoskeleton dynamics and intracellular tension guides human pluripotent stem cell mesoderm specification 197
Characterization of liposomes for the delivery of SiRNAs in the treatment of coronary restenosis 196
Drug mechanochemical activation 196
A novel approach based on low field nuclear magnetic resonance for the detection of the pathological components of the sputum of cystic fibrosis patients 195
Galactosylated polyaspartamide copolymers for siRNA targeted delivery to hepatocellular carcinoma cells 194
Comparison between recombinant baculo and adenoviral-vectors as transfer system in cardiovascular cells 193
Evaluation of the contribution of the elongational factor 1 A isoforms in hepatocellular carcinoma celss growth 193
Rapid and cost-effective xenograft hepatocellular carcinoma model in Zebrafish for drug testing 193
Use of low field nuclear magnetic resonance to monitor lung inflammation and the amount of pathological components in the sputum of cystic fibrosis patients 192
Totale 48.954
Categoria #
all - tutte 164.976
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 164.976


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.308 0 0 0 0 0 0 0 0 0 558 280 470
2021/20224.621 244 297 233 497 197 379 266 252 465 420 447 924
2022/20238.700 750 880 713 912 740 1.091 366 740 830 380 721 577
2023/20246.324 639 547 504 457 588 511 736 796 133 457 518 438
2024/20258.260 364 473 660 710 871 722 533 514 1.034 927 664 788
2025/202614.473 1.767 957 1.217 1.512 1.294 1.484 2.115 500 1.851 1.776 0 0
Totale 74.337